The combination of platelet count and neutrophil lymphocyte ratio is a predictive factor in patients with esophageal squamous cell carcinoma

Translational Oncology

Volumn 7, Issue 5, 2014, Pages 632-637

  Feng, Ji Feng ^a   Huang, Ying ^b   Chen, Qi Xun ^a  

^a ZHEJIANG CANCER HOSPITAL   (China)

^b Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CLINICAL ASSESSMENT; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GLASGOW PROGNOSTIC SCORE; HUMAN; HYPOALBUMINEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUTROPHIL LYMPHOCYTE RATIO; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURVIVAL PREDICTION; THROMBOCYTE COUNT; VERY ELDERLY;

EID: 84915784123     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1016/j.tranon.2014.07.009     Document Type: Article

References (19)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, and Parkin DM (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127, 2893–2897.
2. Corley DA and Buffler PA (2001). Oesophageal and gastric cardia adenocarcinomas: Analysis of regional variation using the cancer incidence in five continents database. Int J Epidemiol 30, 1415–1425.
3. Feng JF, Huang Y, and Zhao Q (2013). Tumor length in elderly patients with esophageal squamous cell carcinoma: Is it a prognostic factor? Ups J Med Sci 118, 145–152.
4. Vizcaino AP, Moreno V, Lambert R, and Parkin DM (2002). Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973–1995. Int J Cancer 99, 860–868.
5. Mantovani A, Allavena P, Sica A, and Balkwill F (2008). Cancer-related inflammation. Nature 454, 436–444.
6. Balkwill F and Mantovani A (2001). Inflammation and cancer: Back to Virchow? Lancet 357, 539–545.
7. Crumley AB, McMillan DC, McKernan M, Going JJ, Shearer CJ, and Stuart RC (2006). An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastrooesophageal cancer. Br J Cancer 94, 1568–1571.
8. Vashist YK, Loos J, Dedow J, Tachezy M, Uzunoglu G, Kutup A, Yekebas EF, and Izbicki JR (2011). Glasgow prognostic score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer. Ann Surg Oncol 18, 1130–1138.
9. Kobayashi T, Teruya M, Kishiki T, Endo D, Takenaka Y, Tanaka H, Miki K, Kobayashi K, and Morita K (2008). Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma. Surgery 144, 729–735.
10. Ishizuka M, Nagata H, Takagi K, Horie T, and Kubota K (2007). Inflammationbased prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246, 1047–1051.
11. Sato H, Tsubosa Y, and Kawano T (2012). Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer. World J Surg 36, 617–622.
12. Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, Altorki NK, and Abrams JA (2011). Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol 18, 3362–3369.
13. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, and Kubota K (2013). Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br J Cancer 109, 401–407.
14. Rice TW, Rusch VW, Ishwaran H, and Blackstone EH, Worldwide Esophageal Cancer Collaboration (2010). Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer 116, 3763–3773.
15. Roberts SA, Hirst WM, Brison DR, and Vail A, towardSET collaboration (2010). Embryo and uterine influences on IVF outcomes: An analysis of a UK multi-centre cohort. Hum Reprod 25, 2792–2802.
16. Stylianou C, Pickles A, and Roberts SA (2013). Using Bonferroni, BIC and AIC to assess evidence for alternative biological pathways: Covariate selection for the multilevel Embryo-Uterus model. BMC Med Res Methodol 13, 73.
17. Ishizuka M, Nagata H, Takagi K, and Kubota K (2009). Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer. Ann Surg 250, 268–272.
18. Nozoe T, Iguchi T, Egashira A, Adachi E, Matsukuma A, and Ezaki T (2011). Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma. Am J Surg 201, 186–191.
19. Hwang JE, Kim HN, Kim DE, Choi HJ, Jung SH, Shim HJ, Bae WK, Hwang EC, Cho SH, and Chung IJ (2011). Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer. BMC Cancer 11, 489.